Spitalul Clinic Judetean Mures
- Address
- lock Available on a paid plan
Gastroenterology and Inflammatory Bowel Disease
At Spitalul Clinic Judetean Mures, clinical research in digestive system diseases focuses on Crohn’s disease, ulcerative colitis, and bile acid diarrhoea. These studies are designed to test new treatment options and assess how well they control symptoms and improve intestinal healing.
- Evaluating therapies for Crohn’s disease and ulcerative colitis
- Studying treatment effectiveness in bile acid diarrhoea
- Improving relief of inflammation and digestive symptoms
The site’s work in this area highlights a strong interest in finding better ways to manage chronic gastrointestinal inflammation and related quality-of-life concerns.
Cardiovascular Medicine and Stroke Prevention
Research in cardiovascular diseases includes acute coronary syndrome, myocardial infarction, atrial fibrillation, heart failure, and atherosclerotic cardiovascular disease. The trials are mainly aimed at preventing major events, reducing complications, and improving long-term cardiovascular outcomes.
- Testing approaches to prevent stroke and recurrent heart events
- Evaluating treatments for atrial fibrillation and heart failure
- Supporting better prevention in high-risk cardiovascular disease
This area reflects a broad effort to improve both acute care and prevention strategies for patients with serious heart and vascular conditions.
Dermatology, Immune-Mediated Disease, and Allergy
Trials in skin and connective tissue diseases and immune system diseases cover plaque psoriasis, prurigo nodularis, and cutaneous lupus erythematosus. The main purpose is to evaluate new therapies that may better control inflammation, itching, and visible skin symptoms.
- Assessing treatments for moderate to severe plaque psoriasis
- Studying options for prurigo nodularis and persistent itch
- Exploring therapies for cutaneous lupus erythematosus
These studies show active interest in improving care for chronic inflammatory skin disorders that can significantly affect daily life.
Oncology and Hematology
The site’s neoplasms research includes breast cancer, prostate cancer, and chronic lymphocytic leukemia. In parallel, work in hemic and lymphatic diseases aims to evaluate new treatments that may improve disease control and patient outcomes.
- Testing therapies for HER2-positive breast cancer
- Studying treatment strategies in high-risk prostate cancer
- Evaluating approaches for chronic lymphocytic leukemia
Research in this field supports the development of more effective cancer and blood-disease treatments at Spitalul Clinic Judetean Mures.
Respiratory and Critical Care Research
Clinical trials in respiratory tract diseases focus on acute respiratory distress syndrome linked to pneumonia or other infections. The aim is to assess new therapies that may help improve breathing, recovery, and survival in severely ill patients.
- Evaluating treatments for ARDS caused by infection
- Exploring ways to improve outcomes in critical respiratory illness
- Supporting better management of severe lung inflammation
This work addresses a high-risk area of care where improved treatment options could make a meaningful difference for hospitalized patients.
Endocrinology and Growth Disorders
Research in hormonal diseases includes Cushing’s disease, growth hormone deficiency, and childhood growth problems such as idiopathic short stature, short stature due to SHOX deficiency, Turner syndrome, and small for gestational age. These trials are designed to assess new treatments and their impact on hormone balance and growth.
- Testing therapies for Cushing’s disease
- Evaluating treatment options for growth failure in children and adolescents
- Studying ways to support healthier growth outcomes
The site’s endocrinology research spans both rare disorders and pediatric growth conditions, with a strong focus on improving long-term care.
Psychiatry and Behavioral Health
Trials in mental disorders and behavioral disciplines focus on schizophrenia. The research is intended to evaluate whether new or added treatments can better reduce symptoms and improve day-to-day functioning for patients with ongoing psychiatric needs.
- Assessing symptom control in schizophrenia
- Studying adjunctive treatment approaches for persistent symptoms
- Supporting improved psychiatric care for hospitalized adults
This area adds an important mental health dimension to the site’s broader clinical research portfolio.
Infectious Disease, Surgery, and Prevention Research
Studies in bacterial infections and mycoses include prevention of post-abdominal surgery incisional infection. The purpose is to test methods that may lower infection risk and improve recovery after surgery.
- Preventing surgical site infection after abdominal procedures
- Evaluating infection-control strategies in surgical care
- Improving postoperative safety and healing
This research supports practical improvements in hospital-based infection prevention and surgical outcomes.
Reproductive Health and Contraception
Within reproductive and urinary physiological phenomena, the site is involved in a study of contraceptive efficacy. The goal is to determine how well the method prevents pregnancy while also assessing overall tolerability and safety.
- Evaluating a new contraceptive option
- Studying pregnancy prevention effectiveness
- Assessing user acceptability and safety
This adds a women’s health perspective to the broader research activity at the site.
Rheumatology and Autoimmune Disease
Research in immune system diseases and skin and connective tissue diseases also includes autoimmune conditions such as lupus. These trials aim to test therapies that may better control inflammation and reduce disease-related skin manifestations.
- Studying treatment effects in cutaneous lupus erythematosus
- Exploring improved control of autoimmune inflammation
- Evaluating symptom relief in chronic immune-mediated disease
Such studies help expand options for patients with complex autoimmune disorders that often require long-term management.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 15 therapeutic areas and 15 of 41 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 12 by active trials.
- 1Merck Sharp & Dohme LLC1active
lock +11 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Janssen Cilag International4trials
lock +5 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Spitalul Clinic Judetean Mures
lock Showing 1 of 33 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Multicenter, Randomized, Double-Blind Placebo-Controlled Phase 3 Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Deucravacitinib (BMS-986165) in Pediatric Subjects with Moderate to Severe Plaque Psoriasis | Bristol-Myers Squibb Services Unlimited Company | Phase III | Recruiting | May 2021 | — |
IMP list
lock Showing 1 of 41 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Milvexian | 3 | Unknown | 2023-08-04 | 2023-11-21 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.
